Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. This is an enormous ...
Eli Lilly & Co. Inc.’s stock rose 2.3% Wednesday ... The trial enrolled 751 participants across the U.S. and Puerto Rico. “Given the increased interest around obesity medications, we conducted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback